WGU Pharmaceutic II (PHAR 636) Midterm Exam Practice Questions with Correct Answers

lOMoAR cPSD|8510046 636 Pharmaceutics II Spring 2022 WGU Pharma ceutic II (PHAR 636) Midterm Exam Pract ice Questions with Correct Answers All 3 versions 1. What is the purpose of a mucoadhesive in a buccal tablet? A. To increase retention time with the buccal mucosa B. To bind the drug for prolonged action C. To provide the bulk needed to form an appropriately sized buccal tablet D. To help solubilize the drug for immediate action 2. Why is the sublingual route inappropriate for retentive formulations? A. high salivary flow B. thin epithelium C. low metabolic activity D. good blood flow 3. A weak base drug is administered orally. In which portion of the GI tract would the drug have the highest number of ionized species? A. stomach B. duodenum C. ileum 1 of many lOMoAR cPSD|8510046 636 Pharmaceutics II Spring 2022 4. Which of the oral dosage forms below would have the fastest onset of action? A. solution B. suspension C. immediate release tablet D. osmosis -controlled release tablet 5. An oral dosage form that does not disintegrate is taken with food. When does this dosage form enter the small intestine? A. MMC Phase 3 B. MMC Phase 2 C. MMC Phase 1 D. MMC Phase 4 E. immediately upon entering the stomach 6. When taken with fatty foods, an oral lipophilic drug may feature improved drug absorption due to enhanced A. dissolution B. disintegration C. deaggregation D. diffusion 1 of many